All filters
Abstracts
Weight Changes, Metabolic Syndrome and Its Relationship With All-Cause Mortality in Persons Living With HIV
W. Han
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Key Population Lay Providers Can Successfully Link Men Who Have Sex With Men Clients to Care After Diagnosing Sexually Transmitted Infections in Community-Based Organizations in Thailand
N. Thammajaruk
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Potential interactions between the pathways to diagnosis of HIV/STI and HIV self-testing: Insights from a qualitative study of gay, bisexual and other men who have sex with men in Singapore
R. Tan
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Identification of Key Influencers for Secondary Distribution of HIV Self-Testing Among Chinese Msm: A Machine Learning Approach
F. Jing
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Acceptability of Self-Sampling for HIV/Sti Testing In Msm
N. Wong
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Personalized HIV Partner Notification Service Recommendation System by Machine Learning For Msm Living With HIV: A Decision Tree Approach
F. Jing
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Evaluating the Integration of Telehealth in Same-Day Antiretroviral Initiation Service During COVID-19 in Bangkok, Thailand
S. Amatavete
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
A High Retention Rate Among Teleprep Users, With Teleprep Implementation Model for HIV Pre-Exposure Prophylaxis in Japan
S. Daisuke
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Growth recovery among Asian children with perinatally acquired HIV infection on first-line combination antiretroviral therapy
T. Sudjaritruk
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Identification and Verification of MSM Key Influencers During Secondary Distribution of HIV Self-Testing: A Machine Ensemble Learning-based Quasi-Experimental Study
Y. Ni
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic
A. Chrysostomou
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Characterization of SARS-CoV-2 variants circulating in Central Italy by deep-sequencing of full-length S gene
M. Bellocchi
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
High sensitivity pool testing for SARS-CoV-2 RNA from throat wash and nasopharyngeal swabs
M. Dusek
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Significant SARS-CoV-2 RNA decay during remdesivir treatment in real life COVID-19 hospitalized patients
L. Piermatteo
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers
S. Marot
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Long-acting HIV capsid inhibitor effective as PrEP in a SHIV rhesus macaque model
E. Bekerman
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Prevalence of genotypic baseline risk factors of cabotegravir+rilpivirine failure among ARV-naïve patients
C. Charpentier
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
HIV-1 subtypes B, G and CRF02_AG transmission cluster in Migrants population followed in Portugal based on sequence data
V. Pimentel
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Low prevalence of archived M184V/I mutations in 3 HIV-1 suppressed, switch studies
R. Wang
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Kinetics of archived M184V mutation in HIV-DNA from highly experienced HIV-infected patients with sustained viral suppression
R. Palich
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
HIV-1 reverse transcriptase natural polymorphism V106I does not alter the susceptibility and the genetic barrier to resistance to Doravirine in vitro.
F. Giammarino
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Virological efficacy of switch to 3TC/DTG in a real life cohort of suppressed HIV-1 patients with or without past M184V – The LAMRES Study
M. Santoro
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Exploratory Analysis of Baseline Phenotypic and Genotypic Parameters in Relation to Antiviral Activity for Fostemsavir (FTR) in Heavily Treatment-Experienced (HTE) Patients in the Phase 3 BRIGHTE Study
A. Merritt
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Determinants of HIV-1 late presentation in patients followed in Europe
M. Miranda
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021